Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant ...

Eli Lilly (LLY) is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

Ford is bringing back certain F250, F350, F450, F550, F650, and F750 Super Duty and Medium Truck vehicles equipped with its 6 ...

According to industry insider Daniel Richtman, Marvel's team is still rewriting the script for the movie after Kevin Fiege ...

STX-478 is under clinical development by Scorpion Therapeutics and currently in Phase II for Endometrial Cancer.

TrafFix Devices, a leading manufacturer and supplier of traffic control devices and crash attenuation products, highlights the Scorpion II Blocker, a cutting-edge truck-mounted attenuator (TMA ...